Rank |
Title |
Year |
PubWeight™‹?› |
1
|
A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity.
|
1992
|
2.74
|
2
|
Continuous cell lines and immune ascitic fluid pools in arbovirus detection.
|
1993
|
2.64
|
3
|
General aspects of the 1987 Rift Valley fever epidemic in Mauritania.
|
1989
|
1.91
|
4
|
Identification of mosquito-borne flavivirus sequences using universal primers and reverse transcription/polymerase chain reaction.
|
1994
|
1.86
|
5
|
Rift Valley fever epizootic in the central highlands of Madagascar.
|
1993
|
1.59
|
6
|
Genetic and serologic relatedness between Mycoplasma fermentans strains and a mycoplasma recently identified in tissues of AIDS and non-AIDS patients.
|
1990
|
1.54
|
7
|
Polio vaccines and the origin of AIDS.
|
1993
|
1.40
|
8
|
Mycoplasmas and leukaemia.
|
1992
|
1.39
|
9
|
Rift Valley fever on the east coast of Madagascar.
|
1992
|
1.35
|
10
|
Type- and group-specific polymerase chain reaction for adenovirus detection.
|
1994
|
1.35
|
11
|
Rapid diagnosis of Rift Valley fever: a comparison of methods for the direct detection of viral antigen in human sera.
|
1989
|
1.34
|
12
|
The impact of dengue haemorrhagic fever on liver function.
|
1997
|
1.32
|
13
|
Sexual and transovarian transmission of Crimean-Congo haemorrhagic fever virus in Hyalomma truncatum ticks.
|
1992
|
1.31
|
14
|
KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma.
|
1997
|
1.27
|
15
|
A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein.
|
1996
|
1.24
|
16
|
Rift Valley fever among domestic animals in the recent West African outbreak.
|
1989
|
1.24
|
17
|
Hepatitis A and B infections in Yaoundé, Cameroon.
|
1989
|
1.23
|
18
|
Development of techniques to analyse the formation of HIV provirus in primary human macrophages.
|
1991
|
1.19
|
19
|
Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations.
|
1989
|
1.18
|
20
|
Expression vectors for quantitating in vivo translational ambiguity: their potential use to analyse frameshifting at the HIV gag-pol junction.
|
1991
|
1.16
|
21
|
Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression.
|
1997
|
1.15
|
22
|
Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever.
|
1989
|
1.14
|
23
|
Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles.
|
1990
|
1.13
|
24
|
Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign.
|
1990
|
1.13
|
25
|
Restriction site mapping of adenovirus type 8 genome types.
|
1991
|
1.12
|
26
|
PCR-based detection and typing of human adenoviruses in clinical samples.
|
1997
|
1.11
|
27
|
Levels of IgM antibodies against dengue virus in Rio de Janeiro, Brazil.
|
1993
|
1.10
|
28
|
A dual dominant selection, dual marker gene amplification model for environmental surveillance of recombinant viral vaccines.
|
1991
|
1.09
|
29
|
Coronary artery lesions and human immunodeficiency virus infection.
|
1993
|
1.08
|
30
|
Nested RT-PCR for detection of sandfly fever virus, serotype Toscana, in clinical specimens, with confirmation by nucleotide sequence analysis.
|
1996
|
1.08
|
31
|
Dengue-2 virus isolation from humans during an epizootic in southeastern Senegal in November, 1990.
|
1992
|
1.07
|
32
|
Rift Valley fever antibody prevalence in domestic ungulates in Cameroon and several west African countries (1989-1992) following the 1987 Mauritanian outbreak.
|
1995
|
1.07
|
33
|
Electrostatic interactions in the early events of VSV infection.
|
1991
|
1.07
|
34
|
Electropherotypes, subgroups and serotypes of human rotavirus strains causing gastroenteritis in infants and young children in Palermo, Italy, from 1985 to 1989.
|
1991
|
1.07
|
35
|
Seroepidemiological study of an acute hepatitis E outbreak in Morocco.
|
1997
|
1.06
|
36
|
In vitro HIV1 infection of human cervical tissue.
|
1995
|
1.06
|
37
|
Changes in Rift Valley fever neutralizing antibody prevalence among small domestic ruminants following the 1987 outbreak in the Senegal River basin.
|
1991
|
1.06
|
38
|
Some properties of the viroid inducing peach latent mosaic disease.
|
1990
|
1.06
|
39
|
PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition?
|
1996
|
1.05
|
40
|
Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells.
|
1990
|
1.04
|
41
|
Cytokine patterns and viral load in lymph nodes during the early stages of SIV infection.
|
1997
|
1.04
|
42
|
A fifth human cytomegalovirus glycoprotein B genotype.
|
1998
|
1.03
|
43
|
PCR analysis of HIV1 infection of macrophages: virus entry is CD4-dependent.
|
1993
|
1.02
|
44
|
Sequence characterization of the adenovirus 31 fibre and comparison with serotypes of subgenera A to F.
|
1996
|
1.02
|
45
|
Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251.
|
1998
|
1.02
|
46
|
On the HIV nef gene product.
|
1992
|
1.01
|
47
|
The hexon genes of adenoviruses of subgenus C: comparison of the variable regions.
|
1993
|
1.01
|
48
|
Analytical study of a Rift Valley fever epidemic.
|
1989
|
1.00
|
49
|
Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR.
|
1995
|
1.00
|
50
|
The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection.
|
1993
|
1.00
|